Regression of diabetic macular edema after subcutaneous exenatide

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Acta Diabetologica

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00592-013-0506-6PMID 23925692
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucagon-like peptide-1 improves proliferation and differentiation of endothelial progenitor cells via upregulating VEGF generation.

  2011cited by this paper
• Effect of Exenatide on Inflammatory and Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus

  2011cited by this paper
• Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats.

  2011cited by this paper
• Salvage of a femoral nonunion after primary non-Hodgkin’s lymphoma of bone: A case report and literature review

  2011cited by this paper
• Diabetic macular edema.

  2010cited by this paper
• Diabetic Macular Edema

  2010cited by this paper
• The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion.

  2002cited by this paper
• The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial

  1995cited by this paper

• Ocular Complications Associated with GLP1 Agonist Therapy

  2026cites this paper
• Semaglutide and the Effects of Glucagon-like Peptide-1 on Vision

  2026cites this paper
• Long acting injectables & implants: advances in intraocular drug delivery.

  2025cites this paper
• Dry Eye in Diabetes: The Indian Diabetic and Endocrine Eye Diseases (INDEED) Review

  2024cites this paper
• Comprehensive review of glucagon-like peptide 1 receptor agonist treatment on the risk of cardiovascular outcomes and retinopathy as diabetic complications.

  2023influential citation
• New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy

  2019cites this paper
• Diabetic Macular Edema.

  2017cites this paper
• Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.

  2015cites this paper
• World Journal of Diabetes

  year unknowncites this paper